The study showed that the ratio of MMP-2/MMP-9 was significantly elevated in preeclamptic women, with high specificity and sensitivity, thus distinguishing pregnancies complicated with preeclampsia from healthy pregnancies, resulting in an accurate biomarker in a high-risk population during the second trimester of gestation [46]. The gene discussed is MMP2; the disease is preeclampsia.